Q Therapeutics, Inc.
Q Therapeutics, Inc.
CIK 0001366541 · Pharmaceutical Preparations
Net margin
-492.6%
as of 2014-12-31
Operating margin
-496.9%
as of 2014-12-31
Revenue YoY growth
2498.9%
as of 2014-12-31
Provenance: Q Therapeutics, Inc.’s most recent Revenue
$680,264
- Filing
- 0001193125-15-114403 (10-K)
- Period
- 2014-01-01 to 2014-12-31
- XBRL tag
- us-gaap:Revenues
- Context
- D_12M_2014_12_31
- Mapping
- seed · confidence 1.00